Reaktion #304854

ord-4c8652fcf6c440eda84b91f98c30781c

Reaktionsgleichung

Br.Nc1nnc2ccc(Cl)nn12
6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-ylamine hydrobromide
Br.Nc1nnc2ccc(Cl)nn12
6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-ylamine hydrobromide
[Na+].[O-]c1ccccc1
sodium phenoxide
O
water
Nc1nnc2ccc(Oc3ccccc3)nn12
title compound
Ausbeute 20.9%
Nc1nnc2ccc(Oc3ccccc3)nn12
6-Phenoxy-[1,2,4]triazolo[4,3-b]pyridazin-3-ylamine
Ausbeute 20.9%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Temperaturby heating to 55° C. for 2 h
  2. 2
    Extraktionextracted three times with dichloromethane
  3. 3
    TrocknenThe combined organic phases were dried over sodium sulfate
  4. 4
    Filtrationafter the desiccant had been filtered off
  5. 5
    Sonstigedried under reduced pressure
  6. 6
    SonstigeThe crude product was purified

Vorschrift

6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-ylamine hydrobromide (W2.001; 200 mg) were initially charged dissolved in NMP (4 ml). Thereafter, sodium phenoxide (185 mg) was introduced at RT. After stirring at RT for one hour, the reaction was completed by heating to 55° C. for 2 h. Subsequently, the mixture was admixed with water and extracted three times with dichloromethane. The combined organic phases were dried over sodium sulfate and, after the desiccant had been filtered off, dried under reduced pressure. The crude product was purified using silica gel with a dichloromethane/methanol gradient. 38 mg of the title compound were obtained in solid form. LC-MS rt: 0.80 min [M+H]+: 228.1 (met. a)

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08198272B2uspto-grants-2012_06